ARCT
NASDAQ
$5.97
Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $20.60 (+245.06%)
Market Cap
$182M
P/B Ratio
0.95
Revenue 5Y CAGR
+43.41%
Free Cash Flow Yield
-32.40%
Price Chart
Valuation
Market Cap$182M
Forward P/E2.48
P/S3.36
P/B0.95
Profitability
Total Revenue (TTM)$55M
Gross Profit (TTM)-$44M
EBITDA-$85M
Profit Margin-143.8%
Operating Margin-1404%
EPS-$2.80
Financial Health
Free Cash Flow Yield-32.40%
Growth & Risk
EPS 5Y CAGR-9.76%
Revenue 5Y CAGR+43.41%
FCF 5Y CAGR-4.96%
Beta (5Y)1.65
Sharpe Ratio-0.42